New FDA Initiatives Aim to Spur Innovation

Pharmaceutical Technology, Pharmaceutical Technology-08-02-2003, Volume 27, Issue 8

Manufacturers face challenges from FDA's plans to streamline the drug review and development processes aimed to spur innovation.